Stonebridge Capital Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-780
Closed -$30.5K – 285
2023
Q3
$30.5K Buy
+780
New +$31.1K ﹤0.01% 428

Other funds holding BME

Stonebridge Capital Advisors's BME Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 780 shares — an estimated $30.5K sold.

Stonebridge Capital Advisors first reported a position in BME in Q3 2023 and held it in 1 quarter. The position peaked at $30.5K in Q3 2023. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 780 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $30.5K.
  • Stonebridge Capital Advisors first reported a position in BlackRock Health Sciences Trust in Q3 2023 and held it in 1 quarter.
  • Stonebridge Capital Advisors's BlackRock Health Sciences Trust position peaked at $30.5K in Q3 2023.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.